𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Controlled release of nerve growth factor from fibrin gel

✍ Scribed by Suk Ho Bhang; Oju Jeon; Cha Yong Choi; Yun Hee Kim Kwon; Byung-Soo Kim


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
275 KB
Volume
80A
Category
Article
ISSN
1549-3296

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Nerve growth factor (NGF) is known to promote the axonal regeneration in injured nerve system. Delivery of NGF for a long period in a controlled manner may enhance the regeneration efficacy. In this study, we investigated whether NGF can be released from fibrin gel for a long period in a controlled manner. We also investigated whether sustained delivery of NGF using fibrin gel can enhance the efficacy of NGF in vitro. The addition of heparin to fibrin gel decreased the rate of NGF release from the fibrin gel. As the concentrations of thrombin and fibrinogen in fibrin gel increased, the NGF release rate decreased significantly, and the initial release burst decreased. NGF was released for up to 14 days in vitro. The bioactivity of NGF released from fibrin gel was assessed by morphological changes of pheochromocytoma (PC12) cells cultured in the presence of NGF‐containing fibrin gel. NGF released from fibrin gel exhibited significantly higher degrees of PC12 cell viability and differentiation than NGF added in a free form daily into the culture medium. This study demonstrates that fibrin gel can release NGF in a sustained, controlled manner and in a bioactive form. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2007


📜 SIMILAR VOLUMES


Rationally designed peptides for control
✍ Stephanie M. Willerth; Philip J. Johnson; Dustin J. Maxwell; Sarah R. Parsons; M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 1 views

## Abstract The purpose of this research was to identify peptide sequences with varying affinity for nerve growth factor (NGF) and use them in the rational design of affinity‐based drug delivery systems. A phage display library (12 amino acid random peptide sequence) was screened against NGF‐conjug

Release rate controls biological activit
✍ Matthew D. Wood; Shelly E. Sakiyama-Elbert 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB 👁 1 views

## Abstract Previously, combinatorial techniques were used to identify peptide sequences exhibiting high, medium, and low affinity for heparin. Bidomain peptides were synthesized containing a transglutaminase sequence for one domain and one of the heparin‐affinity sequences for the other domain. A

Controlled release of glial-derived neur
✍ Matthew D. Wood; Gregory H. Borschel; Shelly E. Sakiyama-Elbert 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 1 views

## Abstract This research evaluated the controlled release of glial‐derived neurotrophic factor (GDNF) from an affinity‐based delivery system (ABDS) as potential treatment for peripheral nerve injury. The ABDS consisted of a bidomain peptide containing a transglutaminase substrate, allowing crossli

Improvement of peripheral nerve regenera
✍ Hailong Yu; Jiang Peng; Quanyi Guo; Li Zhang; Zhi Li; Bin Zhao; Xiang Sui; Yu Wa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

## Abstract Previous studies have demonstrated the potential of growth factors in peripheral nerve regeneration. A method was developed for sustained delivery of nerve growth factor (NGF) for nerve repair with acellular nerve grafts to augment peripheral nerve regeneration. NGF‐containing polymeric

Controlled release of vancomycin from th
✍ Christopher S. Adams; Valentin Antoci Jr.; Gerald Harrison; Payal Patal; Terry A 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 419 KB 👁 1 views

## Abstract Peri‐prosthetic infection remains a serious complication of joint replacement surgery. Herein, we demonstrate that a vancomycin‐containing sol‐gel film on Ti alloy rods can successfully treat bacterial infections in an animal model. The vancomycin‐containing sol‐gel films exhibited pred